Myostatin & activin inhibition
One of 6 mechanistic pathways to 💪 Build muscle & strength · 7 options
Myostatin is the brake. Animals and the handful of humans with loss-of-function mutations are extraordinarily muscular, which makes this the most mechanistically compelling target in the whole field — and the one where delivery has repeatedly defeated good biology.
No commercial myostatin assay exists, so there is nothing here that measures the mechanism directly. What you can do is watch for collateral damage — liver enzymes on anything oral, haematocrit on anything androgenic.
Comprehensive Metabolic Panel (CMP)Complete Blood Count (CBC) with DifferentialIGF-1 (Insulin-like Growth Factor 1)⚗️ Enhanced Athlete — On-Cycle Monitoring covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Follistatin 344
Binds myostatin and activin A directly. The gene-therapy versions produce dramatic hypertrophy in primates. Injected peptide has a short half-life and poor tissue targeting, so the gap between mechanism and result is delivery, not biology.
💉 ACE-083
A follistatin-Fc fusion injected into a specific muscle. It produced real, measurable local hypertrophy in human trials — and did not improve function, which is why development stopped. Growth without strength is a genuinely instructive result.
💉 Bimagrumab
Blocks the activin type-II receptor, so myostatin and activin can't signal at all. Human trials show simultaneous muscle gain and fat loss. The most convincing human data for this pathway by a distance.
💉 YK-11
Increases follistatin in myoblast culture, which is the basis for the myostatin-inhibition claim. Kept in the Vault on Cam's decision despite the SARM-adjacent classification; it is hepatotoxic in practice and bloodwork is not optional.
🧬 Epicatechin
A cocoa flavanol that reduces myostatin and raises follistatin in small human studies. The effect size is nothing like the pharmacological agents — but it is oral, safe and the direction is right.
🧬 Turkesterone
An ecdysteroid claimed to work through a non-androgenic anabolic route. The rodent data is often cited and rarely replicated in humans; product purity is a real problem across the category.
🧬 Ecdysterone
The better-characterised ecdysteroid, with one small human trial showing hypertrophy. Estrogen-receptor-β binding is the proposed mechanism. Interesting, unreplicated.
The other 5 routes to build muscle & strength
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
Myostatin is the brake. Animals and the handful of humans with loss-of-function mutations are extraordinarily muscular, which makes this the most mechanistically compelling target in the whole field — and the one where delivery has repeatedly defeated good biology.
7 options are mapped to this pathway in the Vault, including Follistatin 344, ACE-083, Bimagrumab, YK-11. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 2 carry clinical validation and 5 are mechanistic predictions.
No commercial myostatin assay exists, so there is nothing here that measures the mechanism directly. What you can do is watch for collateral damage — liver enzymes on anything oral, haematocrit on anything androgenic. The markers worth checking are Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC) with Differential, IGF-1 (Insulin-like Growth Factor 1).
Unproven is not the same as ineffective. Of the 7 options on this pathway, 2 have clinical validation and 5 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.